Skip to main content
Diabetes Management Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Diabetes Management Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Published: Jan 2024 163 Pages SKU: IRTNTR70599

Market Overview at a Glance

$13.98 B
Market Opportunity
7.68%
CAGR
7.22
YoY growth 2023-2024(%)

Diabetes Management Devices Market Size 2024-2028

The diabetes management devices market size is forecast to increase by USD 13.98 bn at a CAGR of 7.68% between 2023 and 2028.

  • The market is witnessing significant growth due to the rising global burden of diabetes and the increasing focus on advanced technologies such as artificial pancreas systems. These systems utilize insulin pumps and continuous glucose monitoring sensors to automatically adjust insulin delivery based on real-time glucose levels. Additionally, the integration of artificial intelligence and data analytics in diabetes management devices is revolutionizing the industry, enabling remote patient monitoring and personalized treatment plans. Other trends include the development of insulin pens with advanced features and the adoption of spectroscopy technology for non-invasive blood glucose monitoring. However, the prohibitive cost of diabetes care devices remains a major challenge for market growth.
  • Overall, the market is expected to experience robust growth In the coming years, driven by technological advancements and the increasing prevalence of diabetes.

    • What will be the Size of the Diabetes Management Devices Market during the Forecast Period?

    Diabetes Management Devices Market Size

     Request Free Sample

  • The market encompasses a range of technologies designed to assist individuals in managing their diabetes, including insulin delivery devices, mobile health applications, and disease management tools. With the global diabetic population projected to reach over 592 million by 2035, driven by factors such as obesity rates, smoking, and high cholesterol levels, the market for diabetes care devices is experiencing significant growth. Hospitals and specialty clinics are increasingly adopting minimally invasive devices, such as diabetes lancet devices and diabetes tracker devices, to improve patient care and outcomes. Type 1 diabetes, an autoimmune disease characterized by insulin deficiency, and Type 2 diabetes, often associated with insulin resistance, both require ongoing management to prevent complications, including kidney failure, gangrene, and lower limb amputation.
  • Insulin delivery devices, including insulin pens and blood glucose level monitoring systems, are essential tools in managing both types of diabetes. The market for diabetes management devices is expected to continue expanding as technology advances and the global population ages.

    • How is this Diabetes Management Devices Industry segmented and which is the largest segment?

    The diabetes management devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    • Product
      • Blood glucose monitoring devices
      • Insulin delivery systems
    • Distribution Channel
      • Offline
      • Online
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • UK
        • France
      • Asia
        • China
      • Rest of World (ROW)

      By Product Insights

      The blood glucose monitoring devices segment is estimated to witness significant growth during the forecast period. Diabetes management devices play a crucial role in monitoring and managing blood glucose levels for individuals with diabetes. These devices include a range of products such as insulin delivery systems, continuous monitoring systems, and glucose monitoring devices. Insulin delivery devices, including insulin pumps and pens, facilitate precise insulin administration. Continuous monitoring systems, such as continuous glucose monitoring systems (CGMs) and Mobi insulin pumps, provide real-time glucose level data through wireless transmission and dedicated apps. Glucowear, a continuous glucose monitoring system, offers non-invasive transdermal sensors and spectroscopy technology. Hospital pharmacies, retail pharmacies, and online pharmacies stock these diabetes care devices. The increasing prevalence of diabetes among the obese, elderly population, and those with conditions like high cholesterol levels, smoking, and inactive lifestyles necessitates effective diabetes management.

      Disease management is essential to prevent complications like kidney failure, gangrene, lower limb amputation, heart attack, blindness, and stroke. Diabetes tracker devices, such as diabetes monitoring software and artificial pancreas systems, help healthcare providers analyze glucose patterns and create treatment plans. User-friendly interfaces, visual representations, and medication adherence features enhance the efficacy of treatment. In summary, diabetes management devices, including insulin delivery devices, continuous monitoring systems, and glucose monitoring devices, are essential tools for managing diabetes and preventing complications. These devices offer precision, flexibility, and smart features, making diabetes care more accessible and convenient for individuals with diabetes. Hospital segment, diagnostic centers, diabetes clinics, and healthcare professionals utilize these devices to improve patient care and outcomes.

      Diabetes Management Devices Market Size

      Get a glance at the market report of various segments Request Free Sample

      The Blood glucose monitoring devices segment was valued at USD 12.92 bn in 2018 and showed a gradual increase during the forecast period.

      Regional Analysis

      North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

      Diabetes Management Devices Market Share by Geography

      For more insights on the market size of various regions, Request Free Sample

      The North American the market is a substantial and expanding sector, encompassing products like blood glucose meters, continuous glucose monitoring (CGM) systems, insulin delivery devices, and related accessories. Factors fueling market growth include the escalating diabetes prevalence, growing recognition of glycemic control's significance, and technological innovations in diabetes management. Key players include Abbott Laboratories, Medtronic, and Dexcom, Inc. The market expansion is influenced by the elderly population's increasing diabetes incidence, rising obesity rates, and the need for affordable healthcare options. Diabetes management devices, such as insulin pumps, continuous monitoring systems, and diabetes tracker devices, improve patient outcomes by enabling real-time monitoring, wireless transmission, and dedicated apps.

      These devices aid healthcare providers in creating personalized treatment plans based on glucose patterns and medication adherence. Additionally, non-invasive technologies like transdermal sensors, spectroscopy, and artificial intelligence enhance diabetes care. The market is further segmented into hospitals, specialty clinics, diagnostic centers, hospital pharmacies, retail pharmacies, ambulatory surgery centers, home care, and hospital information systems.

      Market Dynamics

      Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

      What are the key market drivers leading to the rise In the adoption of market?

      Rising global burden of diabetes is the key driver of the market.Diabetes, a chronic condition characterized by high blood sugar levels, affects over 537 million adults worldwide. This number is projected to increase to 643 million by 2030 and 783 million by 2045. The rise in diabetes prevalence is attributed to factors such as obesity, smoking, sedentary lifestyles, and urbanization. Diabetes can lead to severe complications, including kidney failure, lower limb amputation, heart attack, blindness, and stroke, if left untreated. Diabetes management involves disease management, insulin delivery devices, and glucose monitoring systems. Insulin delivery devices include insulin pumps, insulin pens, and continuous insulin infusion systems. Glucose monitoring systems consist of continuous glucose monitors, testing strips, and glucose monitoring devices.

      Mobile health technologies, such as Mobi insulin pumps and Glucowear, offer real-time monitoring and wireless transmission of data to healthcare providers. Hospital pharmacies, retail pharmacies, and online pharmacies provide affordable healthcare options for insulin and diabetes care devices. Hospitals, specialty clinics, diagnostic centers, and diabetes clinics offer treatment plans tailored to individual needs. Minimally invasive devices, such as diabetes lancet devices and diabetes care devices, provide precision and flexibility. The elderly population, particularly those with type 1 diabetes, an autoimmune disease, benefit from user-friendly interfaces and visual representations of glucose patterns. The market for diabetes management devices is driven by the efficacy of treatment, the need for medication adherence, and the growing demand for smart technology.

      Healthcare professionals use data analytics, artificial intelligence, and electronic health records to optimize treatment plans and improve patient outcomes. Ambulatory surgery centers, home care, and hospital information systems facilitate seamless data-sharing capabilities and connectivity. Pharmaceutical manufacturers invest in research and development to create innovative diabetes management devices, such as artificial pancreas systems and smart insulin pens.

      What are the market trends shaping the Diabetes Management Devices market?

      Growing focus on artificial pancreas is the upcoming market trend.The market is experiencing significant growth due to the increasing focus on advanced technologies for diabetes care. Artificial pancreas systems, which integrate continuous glucose monitors (CGMs) and insulin pumps, are gaining popularity for their ability to automatically regulate blood glucose levels. These systems, which effectively manage glucose levels, particularly during overnight hours, are expected to see substantial growth due to technological advancements and rising demand for effective diabetes management solutions. Artificial intelligence algorithms and machine learning techniques have been integrated into these systems, enabling them to learn and adapt to individual glucose patterns, thereby improving glycemic control and reducing the risk of hypoglycemia.

      The market for diabetes management devices is driven by the diabetic population's increasing need for minimally invasive, user-friendly, and real-time monitoring solutions. The obesity rates, smoking, high cholesterol levels, and inactive lifestyles contribute to the rising prevalence of diabetes, leading to an increased demand for affordable healthcare options and disease management devices. The market includes various devices such as insulin delivery devices (insulin pumps, insulin pens), glucose monitoring devices (CGMs, testing strips, lancets), diabetes tracker devices, and diabetes care devices (insulin syringes, diabetes lancet devices). Healthcare providers, hospitals, specialty clinics, diagnostic centers, hospital pharmacies, retail pharmacies, ambulatory surgery centers, home care, and online pharmacies are key players In the market.

      The market is expected to grow significantly In the forecast period due to the increasing prevalence of diabetes, especially among the elderly population, and the need for effective diabetes management solutions.

      What challenges does the market face during its growth?

      Prohibitive cost of diabetes care devices is a key challenge affecting the industry growth.Diabetes management devices play a crucial role in ensuring effective diabetes care for the growing diabetic population. Insulin delivery devices, such as insulin pumps and continuous monitoring systems, have gained popularity due to their ability to provide real-time glucose level readings and flexible insulin administration. For instance, mobi insulin pumps and glucowear offer minimally invasive solutions for continuous glucose monitoring. However, the high cost of these devices poses a challenge for many patients, particularly those in developing countries. Traditional diabetes care devices, including insulin syringes, lancets, and insulin pens, remain widely used due to their affordability. The healthcare industry continues to innovate, offering advanced solutions like artificial pancreas systems and non-invasive transdermal sensors.

      These devices enable more precise insulin administration and real-time monitoring, improving patient outcomes. Despite these advancements, diabetes management remains a significant challenge due to factors like obesity rates, smoking, high cholesterol levels, and an aging population. The hospital segment, including hospitals, specialty clinics, diagnostic centers, and ambulatory surgery centers, plays a critical role in diabetes care. These facilities provide access to healthcare professionals, point-of-care testing devices, and electronic health records, enabling effective disease management and data-sharing capabilities. The increasing prevalence of diabetes, driven by lifestyle factors and an aging population, necessitates the development of affordable healthcare options. Online pharmacies and retail pharmacies offer accessible solutions for patients, while hospital pharmacies and medical devices companies collaborate to provide integrated diabetes care solutions.

      Diabetes management devices have become essential tools for managing blood glucose levels and improving patient outcomes. These devices offer user-friendly interfaces, visual representations, and medication adherence features, ensuring effective treatment plans. With the integration of smart technology, continuous glucose monitors, testing strips, and CGM systems provide real-time data, enabling healthcare providers to make informed decisions and adjust treatment plans accordingly. The diabetes care market is expected to grow significantly due to the increasing prevalence of diabetes, the need for effective disease management, and the development of innovative solutions. The market dynamics are driven by factors like an aging population, increased stress levels, unhealthy diets, and sedentary lifestyles.

      The market is also influenced by technological advancements, such as artificial intelligence, data analytics, and wireless transmission capabilities. In conclusion, diabetes management devices play a vital role in ensuring effective diabetes care for the growing diabetic population. With the integration of smart technology and continuous monitoring capabilities, these devices offer improved patient outcomes and more precise treatment plans. However, affordability remains a significant challenge, necessitating the development of accessible solutions for patients. The diabetes care market is expected to grow significantly, driven by factors like an aging population, technological advancements, and the need for effective disease management.

      Exclusive Customer Landscape

      The diabetes management devices market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the diabetes management devices market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

      Diabetes Management Devices Market Share by Geography

       Customer Landscape

      Key Companies & Market Insights

      Companies are implementing various strategies, such as strategic alliances, diabetes management devices market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

      Abbott Laboratories - The company provides a range of diabetes management devices for both personal and healthcare settings. These include the FreeStyle Freedom Lite, FreeStyle Lite, and FreeStyle Libre glucose monitoring systems for individual use. For hospitals and healthcare facilities, the company offers the FreeStyle Optium Neo and FreeStyle Precision Pro blood glucose and ketone monitoring systems. These devices enable effective diabetes management through accurate and timely glucose level monitoring, contributing to improved patient outcomes and overall healthcare efficiency.

      The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

      • Abbott Laboratories
      • ACON Laboratories Inc.
      • B.Braun SE
      • Becton Dickinson and Co.
      • Bionime Corp.
      • Dexcom Inc.
      • Eli Lilly and Co.
      • F. Hoffmann La Roche Ltd.
      • iHealth Labs Inc.
      • Insulet Corp.
      • LifeScan IP Holdings LLC
      • Medtronic Plc
      • Nemaura Medical Inc.
      • Nipro Corp.
      • Nova Biomedical Corp.
      • Novo Nordisk AS
      • PHC Holdings Corp.
      • Prodigy Diabetes Care LL
      • Tandem Diabetes Care Inc.
      • WellDoc Inc.

      Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

      Research Analyst Overview

      Diabetes, an autoimmune disease characterized by elevated blood glucose levels, affects a significant population worldwide. The prevalence of diabetes continues to rise due to various factors, including an increasing obesity rate, sedentary lifestyles, and unhealthy dietary habits. This chronic condition poses various health risks, such as kidney failure, lower limb amputation, blindness, heart attack, stroke, and even mortality. To manage diabetes effectively, various devices and technologies have emerged In the market. Insulin delivery devices, such as insulin pumps and insulin pens, have gained popularity due to their precision and flexibility in insulin administration. These devices offer users the ability to manage their blood glucose levels more effectively, leading to improved health outcomes.

      The integration of mobile health technology in diabetes management has revolutionized the way healthcare is delivered. Mobi insulin pumps, continuous monitoring systems, and diabetes tracker devices allow users to monitor their glucose levels in real-time, enabling them to make informed decisions regarding their treatment plans. Hospitals and specialty clinics have adopted diabetes devices to improve patient care and reduce hospital stays. Diabetes care devices, such as glucowear, are used extensively in hospitals and diagnostic centers to monitor and manage patients' blood glucose levels. Hospital pharmacies and retail pharmacies stock a wide range of diabetes devices, including insulin pumps, insulin syringes, lancets, and testing strips, to cater to the needs of diabetic patients.

      The elderly population is particularly vulnerable to diabetes, and the market for diabetes devices caters to their unique needs. Minimally invasive devices, such as transdermal sensors, have gained popularity due to their ease of use and non-invasive nature, making them suitable for elderly patients. The diabetes devices market is driven by the increasing prevalence of diabetes and the need for affordable healthcare options. Artificial pancreas systems, continuous glucose monitors, and glucose monitoring devices are becoming increasingly popular due to their efficacy in managing diabetes. These devices offer real-time monitoring, wireless transmission, and dedicated apps, making diabetes management more accessible and user-friendly.

      Healthcare providers play a crucial role In the adoption of diabetes devices. The integration of diabetes devices into electronic health records, hospital information systems, and point-of-care testing devices enables healthcare professionals to access patient data and provide personalized treatment plans. The future of diabetes device technology lies In the integration of artificial intelligence and data analytics. These technologies enable precision insulin dosing, real-time glucose pattern analysis, and personalized treatment plans. Smart technology, such as smart insulin pens and smart pumps, offer connectivity and data-sharing capabilities, enabling seamless communication between healthcare providers and patients. In conclusion, the diabetes devices market is driven by the increasing prevalence of diabetes, the need for affordable healthcare options, and the integration of mobile health technology and artificial intelligence.

      These devices offer precision, flexibility, and user-friendly interfaces, making diabetes management more accessible and effective for patients. The future of diabetes device technology lies In the integration of advanced technologies, such as artificial intelligence and data analytics, to provide personalized and effective treatment plans for diabetic patients.

      Market Scope

      Report Coverage

      Details

      Page number

      163

      Base year

      2023

      Historic period

      		 2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 7.68%

      Market growth 2024-2028

      USD 13.98 billion

      Market structure

      Fragmented

      YoY growth 2023-2024(%)

      7.22

      Key countries

      US, Germany, France, UK, and China

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      What are the Key Data Covered in this Diabetes Management Devices Market Research and Growth Report?

      • CAGR of the Diabetes Management Devices industry during the forecast period
      • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
      • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
      • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
      • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
      • Thorough analysis of the market’s competitive landscape and detailed information about companies
      • Comprehensive analysis of factors that will challenge the diabetes management devices market growth of industry companies

      We can help! Our analysts can customize this diabetes management devices market research report to meet your requirements.

      Get in touch

       

      1 Executive Summary

      • 1.1 Market overview
        • Exhibit 01: Executive Summary – Chart on Market Overview
        • Exhibit 02: Executive Summary – Data Table on Market Overview
        • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
        • Exhibit 04: Executive Summary – Chart on Market by Geography
        • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
        • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
        • Exhibit 07: Executive Summary – Chart on Incremental Growth
        • Exhibit 08: Executive Summary – Data Table on Incremental Growth
        • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

      2 Market Landscape

      • 2.1 Market ecosystem
        • Exhibit 10: Parent market
        • Exhibit 11: Market Characteristics

      3 Market Sizing

      • 3.1 Market definition
        • Exhibit 12: Offerings of vendors included in the market definition
      • 3.2 Market segment analysis
        • Exhibit 13: Market segments
      • 3.3 Market size 2023
        • 3.4 Market outlook: Forecast for 2023-2028
          • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
          • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

        4 Historic Market Size

        • 4.1 Global diabetes management devices market 2018 - 2022
          • Exhibit 18: Historic Market Size – Data Table on global diabetes management devices market 2018 - 2022 ($ billion)
        • 4.2 Product Segment Analysis 2018 - 2022
          • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
        • 4.3 Distribution Channel Segment Analysis 2018 - 2022
          • Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
        • 4.4 Geography Segment Analysis 2018 - 2022
          • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
        • 4.5 Country Segment Analysis 2018 - 2022
          • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

        5 Five Forces Analysis

        • 5.1 Five forces summary
          • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
        • 5.2 Bargaining power of buyers
          • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
        • 5.3 Bargaining power of suppliers
          • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
        • 5.4 Threat of new entrants
          • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
        • 5.5 Threat of substitutes
          • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
        • 5.6 Threat of rivalry
          • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
        • 5.7 Market condition
          • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

        6 Market Segmentation by Product

        • 6.1 Market segments
          • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
          • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
        • 6.2 Comparison by Product
          • Exhibit 32: Chart on Comparison by Product
          • Exhibit 33: Data Table on Comparison by Product
        • 6.3 Blood glucose monitoring devices - Market size and forecast 2023-2028
          • Exhibit 34: Chart on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 35: Data Table on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 36: Chart on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
          • Exhibit 37: Data Table on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
        • 6.4 Insulin delivery systems - Market size and forecast 2023-2028
          • Exhibit 38: Chart on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 39: Data Table on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 40: Chart on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
          • Exhibit 41: Data Table on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
        • 6.5 Market opportunity by Product
          • Exhibit 42: Market opportunity by Product ($ billion)
          • Exhibit 43: Data Table on Market opportunity by Product ($ billion)

        7 Market Segmentation by Distribution Channel

        • 7.1 Market segments
          • Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
          • Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
        • 7.2 Comparison by Distribution Channel
          • Exhibit 46: Chart on Comparison by Distribution Channel
          • Exhibit 47: Data Table on Comparison by Distribution Channel
        • 7.3 Offline - Market size and forecast 2023-2028
          • Exhibit 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
          • Exhibit 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
        • 7.4 Online - Market size and forecast 2023-2028
          • Exhibit 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 54: Chart on Online - Year-over-year growth 2023-2028 (%)
          • Exhibit 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
        • 7.5 Market opportunity by Distribution Channel
          • Exhibit 56: Market opportunity by Distribution Channel ($ billion)
          • Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

        8 Customer Landscape

        • 8.1 Customer landscape overview
          • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

        9 Geographic Landscape

        • 9.1 Geographic segmentation
          • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
          • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
        • 9.2 Geographic comparison
          • Exhibit 61: Chart on Geographic comparison
          • Exhibit 62: Data Table on Geographic comparison
        • 9.3 North America - Market size and forecast 2023-2028
          • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
          • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
        • 9.4 Europe - Market size and forecast 2023-2028
          • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
          • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
        • 9.5 Asia - Market size and forecast 2023-2028
          • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
          • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
        • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
          • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
          • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
        • 9.7 US - Market size and forecast 2023-2028
          • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
          • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
        • 9.8 Germany - Market size and forecast 2023-2028
          • Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
          • Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
        • 9.9 China - Market size and forecast 2023-2028
          • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
          • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
        • 9.10 France - Market size and forecast 2023-2028
          • Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
          • Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
        • 9.11 UK - Market size and forecast 2023-2028
          • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
          • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
          • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
        • 9.12 Market opportunity by geography
          • Exhibit 99: Market opportunity by geography ($ billion)
          • Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

        10 Drivers, Challenges, and Trends

        • 10.1 Market drivers
          • 10.2 Market challenges
            • 10.3 Impact of drivers and challenges
              • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
            • 10.4 Market trends

              11 Vendor Landscape

              • 11.1 Overview
                • 11.2 Vendor landscape
                  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
                • 11.3 Landscape disruption
                  • Exhibit 103: Overview on factors of disruption
                • 11.4 Industry risks
                  • Exhibit 104: Impact of key risks on business

                12 Vendor Analysis

                • 12.1 Vendors covered
                  • Exhibit 105: Vendors covered
                • 12.2 Market positioning of vendors
                  • Exhibit 106: Matrix on vendor position and classification
                • 12.3 Abbott Laboratories
                  • Exhibit 107: Abbott Laboratories - Overview
                  • Exhibit 108: Abbott Laboratories - Business segments
                  • Exhibit 109: Abbott Laboratories - Key news
                  • Exhibit 110: Abbott Laboratories - Key offerings
                  • Exhibit 111: Abbott Laboratories - Segment focus
                • 12.4 B.Braun SE
                  • Exhibit 112: B.Braun SE - Overview
                  • Exhibit 113: B.Braun SE - Business segments
                  • Exhibit 114: B.Braun SE - Key news
                  • Exhibit 115: B.Braun SE - Key offerings
                  • Exhibit 116: B.Braun SE - Segment focus
                • 12.5 Becton Dickinson and Co.
                  • Exhibit 117: Becton Dickinson and Co. - Overview
                  • Exhibit 118: Becton Dickinson and Co. - Business segments
                  • Exhibit 119: Becton Dickinson and Co. - Key news
                  • Exhibit 120: Becton Dickinson and Co. - Key offerings
                  • Exhibit 121: Becton Dickinson and Co. - Segment focus
                • 12.6 Bionime Corp.
                  • Exhibit 122: Bionime Corp. - Overview
                  • Exhibit 123: Bionime Corp. - Product / Service
                  • Exhibit 124: Bionime Corp. - Key offerings
                • 12.7 Eli Lilly and Co.
                  • Exhibit 125: Eli Lilly and Co. - Overview
                  • Exhibit 126: Eli Lilly and Co. - Product / Service
                  • Exhibit 127: Eli Lilly and Co. - Key news
                  • Exhibit 128: Eli Lilly and Co. - Key offerings
                • 12.8 F. Hoffmann La Roche Ltd.
                  • Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
                  • Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
                  • Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
                  • Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
                  • Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
                • 12.9 iHealth Labs Inc.
                  • Exhibit 134: iHealth Labs Inc. - Overview
                  • Exhibit 135: iHealth Labs Inc. - Product / Service
                  • Exhibit 136: iHealth Labs Inc. - Key offerings
                • 12.10 Insulet Corp.
                  • Exhibit 137: Insulet Corp. - Overview
                  • Exhibit 138: Insulet Corp. - Product / Service
                  • Exhibit 139: Insulet Corp. - Key news
                  • Exhibit 140: Insulet Corp. - Key offerings
                • 12.11 LifeScan IP Holdings LLC
                  • Exhibit 141: LifeScan IP Holdings LLC - Overview
                  • Exhibit 142: LifeScan IP Holdings LLC - Product / Service
                  • Exhibit 143: LifeScan IP Holdings LLC - Key offerings
                • 12.12 Medtronic Plc
                  • Exhibit 144: Medtronic Plc - Overview
                  • Exhibit 145: Medtronic Plc - Business segments
                  • Exhibit 146: Medtronic Plc - Key news
                  • Exhibit 147: Medtronic Plc - Key offerings
                  • Exhibit 148: Medtronic Plc - Segment focus
                • 12.13 Nemaura Medical Inc.
                  • Exhibit 149: Nemaura Medical Inc. - Overview
                  • Exhibit 150: Nemaura Medical Inc. - Product / Service
                  • Exhibit 151: Nemaura Medical Inc. - Key offerings
                • 12.14 Nipro Corp.
                  • Exhibit 152: Nipro Corp. - Overview
                  • Exhibit 153: Nipro Corp. - Business segments
                  • Exhibit 154: Nipro Corp. - Key offerings
                  • Exhibit 155: Nipro Corp. - Segment focus
                • 12.15 Nova Biomedical Corp.
                  • Exhibit 156: Nova Biomedical Corp. - Overview
                  • Exhibit 157: Nova Biomedical Corp. - Product / Service
                  • Exhibit 158: Nova Biomedical Corp. - Key offerings
                • 12.16 Novo Nordisk AS
                  • Exhibit 159: Novo Nordisk AS - Overview
                  • Exhibit 160: Novo Nordisk AS - Business segments
                  • Exhibit 161: Novo Nordisk AS - Key offerings
                  • Exhibit 162: Novo Nordisk AS - Segment focus
                • 12.17 PHC Holdings Corp.
                  • Exhibit 163: PHC Holdings Corp. - Overview
                  • Exhibit 164: PHC Holdings Corp. - Business segments
                  • Exhibit 165: PHC Holdings Corp. - Key offerings
                  • Exhibit 166: PHC Holdings Corp. - Segment focus

                13 Appendix

                • 13.1 Scope of the report
                  • 13.2 Inclusions and exclusions checklist
                    • Exhibit 167: Inclusions checklist
                    • Exhibit 168: Exclusions checklist
                  • 13.3 Currency conversion rates for US$
                    • Exhibit 169: Currency conversion rates for US$
                  • 13.4 Research methodology
                    • Exhibit 170: Research methodology
                    • Exhibit 171: Validation techniques employed for market sizing
                    • Exhibit 172: Information sources
                  • 13.5 List of abbreviations
                    • Exhibit 173: List of abbreviations

                    Research Methodology

                    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                    INFORMATION SOURCES

                    Primary sources

                    • Manufacturers and suppliers
                    • Channel partners
                    • Industry experts
                    • Strategic decision makers

                    Secondary sources

                    • Industry journals and periodicals
                    • Government data
                    • Financial reports of key industry players
                    • Historical data
                    • Press releases

                    DATA ANALYSIS

                    Data Synthesis

                    • Collation of data
                    • Estimation of key figures
                    • Analysis of derived insights

                    Data Validation

                    • Triangulation with data models
                    • Reference against proprietary databases
                    • Corroboration with industry experts

                    REPORT WRITING

                    Qualitative

                    • Market drivers
                    • Market challenges
                    • Market trends
                    • Five forces analysis

                    Quantitative

                    • Market size and forecast
                    • Market segmentation
                    • Geographical insights
                    • Competitive landscape

                    Interested in this report?

                    Get your sample now to see our research methodology and insights!

                    Download Now

                    Frequently Asked Questions

                    Diabetes Management Devices market growth will increase by $ 13.98 bn during 2024-2028 .

                    The Diabetes Management Devices market is expected to grow at a CAGR of 7.68% during 2024-2028 .

                    Diabetes Management Devices market is segmented by Product( Blood glucose monitoring devices, Insulin delivery systems) Distribution Channel( Offline, Online, Asia, ROW)

                    Abbott Laboratories, ACON Laboratories Inc., B.Braun SE, Becton Dickinson and Co., Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., iHealth Labs Inc., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, Nemaura Medical Inc., Nipro Corp., Nova Biomedical Corp., Novo Nordisk AS, PHC Holdings Corp., Prodigy Diabetes Care LL, Tandem Diabetes Care Inc., WellDoc Inc. are a few of the key vendors in the Diabetes Management Devices market.

                    North America will register the highest growth rate of 41% among the other regions. Therefore, the Diabetes Management Devices market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

                    US, Germany, France, UK, China

                    • Rising global burden of diabetesDiabetes is a chronic disease when the body cannot use insulin effectively or the pancreas produces insufficient insulin. Hyperglycemia or increased blood sugar can result in severe damage or complications is the driving factor this market.
                    • which may become life-threatening to the individual if left untreated. The global burden of the disease is rising at a rapid pace. In 2021 is the driving factor this market.
                    • approximately 537 million adults (20-79 years) had diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The growing incidence of type 1 and type 2 diabetes will significantly increase healthcare costs. The factors contributing to the increase in the diabetic population include obesity is the driving factor this market.
                    • smoking is the driving factor this market.
                    • a sedentary lifestyle is the driving factor this market.
                    • and growing urbanization. Furthermore is the driving factor this market.
                    • the incidence of diabetes is higher in the older population. Hence is the driving factor this market.
                    • the increase in the number of people with diabetes is driving the demand for diabetes management devices such as glucose meters is the driving factor this market.
                    • continuous glucose monitoring systems is the driving factor this market.
                    • and insulin delivery devices is the driving factor this market.
                    • which will drive the growth of the market in focus in the forecast period. is the driving factor this market.

                    The Diabetes Management Devices market vendors should focus on grabbing business opportunities from the Blood glucose monitoring devices segment as it accounted for the largest market share in the base year.